CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Linical Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Linical Co Ltd
10F, Shin-Osaka Brick Bldg
1-6-1, Miyahara
Phone: +81 661502478p:+81 661502478 OSAKA-SHI, OSK  532-0003  Japan Ticker: 21832183
Business Summary
Linical Co., Ltd. is a Japan-based company mainly engaged in the contract research organization (CRO) business for drug companies. The Company operates in two businesses. The CRO segment is engaged in the provision of contract monitoring, quality management and consulting services for phase II and phase III in drug development processes. The Pharmaceutical Sales Support segment is engaged in provision of pharmaceutical sales support for medical institutions in the downstream market.
(Source: F-4)

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-Yes---

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/20243/31/2024Yes----

Industries
SIC Code Description
8731 Commercial physical and biological research
8742 Management consulting services
7389 Business services, not elsewhere classified
7374 Computer processing and data preparation and processing services

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
President, Executive President, CEO, CCO, Chief Director of Development, Director of Ikuyaku BU in KazuhiroHatano 59 6/26/2024 2/1/2010
Executive Officer, Chief Financial Officer, Manager of Accounting & Finance Unit AkihiroTakahashi 56 6/26/2024 4/1/2007
Executive Officer, Chief Technical Officer, Director of Drug Discovery Support in Main Development ToshiakiNagafuji 6/26/2024 6/26/2024
12 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Accelovance, Inc. 2275 Research Boulevard Rockville MD United States

Business Names
Business Name
2183
Accelovance, Inc.
Linical Co., Ltd.
Nuvisan CDD Holding GmbH

General Information
Number of Employees: 662 (As of 3/31/2024)
Outstanding Shares: 22,586,431 (As of 9/30/2024)
Shareholders: 4,986
Stock Exchange: TYO
Fax Number: +81 661502675


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024